Latest From Biotech Now

Five Keys to Making Biotech Flourish in China

baier-china

As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological development in its 12th Five-year Plan. During the keynote lunch of the China Day special program at the 2012 BIO International Convention, David W. Beier, senior vice president at Amgen and former chief domestic policy advisor to Vice President Al Gore, outlined the 5 keys to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Measuring the Impact of Innovation

USPTO

By Joe Allen, President, Allen and Associates It’s always an indication of interest and importance in a topic when a panel draws a standing room only crowd. And that was the case with the Measuring the Impacts of Innovation: What is the Future of Tech Transfer? session at the 2012 BIO International Convention. The panel focused on the need to help policy makers, institutions and the public identify appropriate measures for how publicly funded R&D Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Official Bloggers Preview the Convention

Official Blogger

Want to know what to expect at the 2012 BIO International Convention? Find out from our BIO Official Bloggers: “… most importantly for this blog, the Boston area is home to, arguably, the United State’s most vibrant biotech scene.  Data from Ernst & Young’s Beyond Borders report from 2011 show that New England biotech (consisting primarily of the Boston area) had 45 public companies in 2010, second only to the San Francisco Bay Area, with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Biotech Companies are Bringing Innovation to Global Health

Don Joseph

By Don Joseph, CEO, BIO Ventures for Global Health In March, we at BIO Ventures for Global Health (BVGH) released a report, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape, which showed that small- to medium-sized biotechnology companies are participating in a high percentage (41 percent) of projects targeting neglected diseases of the developing world. The findings of this report were surprising, given the financial risks these companies Read More >

Events  |  2 Comments  |  Email This Post
Tags: , , , ,

Out and About in Boston During the BIO International Convention

Bob Coughlin

By Bob Coughlin, President & CEO, MassBio You will surely be very busy during your time at the 2012 BIO International Convention but you might find you have a little downtime to explore Boston. If you’re looking for suggestions, here are some of my favorite places to see, things to do, and restaurants to enjoy in the city. First of all, let me mention the Red Sox are home… Fenway Park, the oldest Major League Baseball Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,